Thus, utilizing IL-6 as an additional biomarker next to the granulocyte-to-lymphocyte ratio may enable more precise characterization of sepsis subentities, facilitating earlier diagnosis and tailored therapeutic interventions to prevent irreversible organ damage. Here, IL6 is linked to Sepsis.